Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Nanalysis Scientific ( (TSE:NSCI) ) has shared an announcement.
Nanalysis Scientific Corp. has entered into a five-year OEM supplier and technology licensing agreement with IMRIS Imaging, Inc., enhancing its position in the MRI technology market. This deal, which includes an upfront payment, strengthens Nanalysis’s strategic focus on leveraging its core electronics and software across various magnetic resonance applications, promising scalable growth opportunities and reinforcing its collaboration with IMRIS.
More about Nanalysis Scientific
Nanalysis Scientific Corp. is a leader in developing and manufacturing portable Nuclear Magnetic Resonance (NMR) spectrometers, serving industries such as pharma, biotech, energy, food, materials, and security. The company also provides maintenance services for imaging equipment, supported by a significant contract with the Canadian Air Transport Security Authority.
Average Trading Volume: 127,533
Technical Sentiment Signal: Sell
Current Market Cap: C$21.24M
For detailed information about NSCI stock, go to TipRanks’ Stock Analysis page.